Improving Glaucoma Care with a New Eye Scan
Clinical glaucoma management enabled by visible-light OCT
This project is developing a new type of eye scan called visible-light OCT to help doctors better diagnose and track glaucoma in patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11178309 on NIH RePORTER |
What this research studies
We are working to create and test a new imaging tool that uses visible light to look at the eye. This tool aims to measure very tiny changes in the retina, which is the light-sensitive tissue at the back of your eye, and also check how much oxygen is in your retinal blood vessels. By seeing these details, doctors hope to find glaucoma earlier and understand how it changes over time, even when standard tests might not show much. This could lead to more personalized and effective treatment plans for patients with glaucoma.
Who could benefit from this research
Good fit: Patients with glaucoma or those at risk for glaucoma who are seeking advanced diagnostic and monitoring tools may be ideal candidates for future applications of this technology.
Not a fit: Patients without glaucoma or other eye conditions that affect retinal structure or oxygen saturation may not directly benefit from this specific diagnostic tool.
Why it matters
Potential benefit: If successful, this new scanning technology could provide earlier and more accurate detection of glaucoma progression, allowing for more timely and effective treatment adjustments.
How similar studies have performed: While visible-light OCT is a novel application for glaucoma, optical coherence tomography (OCT) is a widely successful and established imaging technique in ophthalmology.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Zhang, Hao F — Northwestern University
- Study coordinator: Zhang, Hao F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.